US 11110099
Natural combination hormone replacement formulations and therapies
granted A61KA61K31/565A61K31/57
Quick answer
US patent 11110099 (Natural combination hormone replacement formulations and therapies) held by Compass Therapeutics LLC expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K47/10, A61K47/14